Medtronic Beats Back Axonics’ Challenge To InterStim Patents
Executive Summary
The US patent office has upheld all seven patents at issue, with the verdict on the final three having come on 22 September.
You may also be interested in...
FDA Clarifies Software Link In Abbott COVID-19 Lab Test Recall
The recall is related to the software’s mixing parameters, which may cause false positives if test samples contaminate each other.
Abbott COVID-19 Lab Test Recall Deemed High-Risk Class I
The recall is related to potential false positives that may occur if a genuine positive test sample overflows into an adjacent sample that would have otherwise tested negative.
COVID-19: Report Finds Staffing, IT Issues Posed Challenges To EUA Process
The agency asked consultants Booz Allen Hamilton to evaluate its handling of diagnostic EUAs as a way to prepare for potential future pandemics.